• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Most COVID-19 Patients in Addis Ababa Recovered Within a Week of Home-Based Care

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
Most COVID-19 Patients in Addis Ababa Recovered Within a Week of Home-Based Care

Most COVID-19 Patients in Addis Ababa Recovered Within a Week of Home-Based Care

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Most COVID-19 patients managed through home-based isolation and care in Addis Ababa recovered within about a week, according to a retrospective cohort study published in BMC Infectious Diseases. The study, conducted in Ethiopia’s capital, reported an overall cumulative recovery rate of 88.6 percent, with 241 of 272 patients recovering during the observation period.

The median time to recovery was seven days overall. Patients who had been vaccinated recovered in a median of seven days, while unvaccinated patients took a median of eight days. Recovery incidence densities were 11.64 per 100 person-days overall, 13.19 among vaccinated patients, and 10.34 among unvaccinated patients.

The researchers set out to determine time to recovery and its predictors among COVID-19 patients receiving home-based isolation and care services in Addis Ababa. The city carried a large share of Ethiopia’s cases, and most infections there were managed through home-based isolation rather than in health facilities.

The study used a retrospective cohort design. Sample size was calculated using the Schoenfeld formula, and the analysis covered biomedical, behavioral, and nutritional variables. Statistical methods included Kaplan–Meier estimation, log-rank tests, and both bivariable and multivariable Cox regression. Model adequacy was assessed with Schoenfeld residuals, Cox–Snell residuals, and Harrell’s C-index.

Several factors predicted faster recovery. Vaccination was associated with a higher hazard of recovery, with an adjusted hazard ratio of 1.62. Prior infection had an adjusted hazard ratio of 2.11, age 30 to 39 years had an adjusted hazard ratio of 2.13, and absence of comorbidity had an adjusted hazard ratio of 1.87.

Other factors were linked to slower recovery. Non-use of masks had an adjusted hazard ratio of 0.39, smoking 0.44, and public-transport use 0.45. Abnormal body mass index was also associated with slower recovery, with adjusted hazard ratios of 0.38 for underweight and 0.67 for overweight patients.

Within the vaccinated group, the cumulative recovery rate reached 91.9 percent, compared with 85.3 percent among unvaccinated patients. These figures describe the observed recovery proportions in this cohort and reflect the associations reported in the multivariable analysis.

The authors concluded that recovery time was short and associated with vaccination, comorbidity, prior infection, and preventive behaviors including mask use and hand hygiene. They suggested that advocating vaccination, integrating comorbidity management, and reinforcing preventive practices could optimize home-based isolation programs, reduce facility burden, and inform policy.

Because the study was retrospective and confined to a single city’s home-based care program, its findings describe recovery patterns and predictors within that setting rather than effects demonstrated in an experimental design. The authors also noted that evidence on recovery trajectories and predictors from sub-Saharan Africa has been limited, which they cited as the gap this analysis aimed to address.

The article was published open access on 24 October 2026 and shared as an early version that is citable and carries a permanent DOI, subject to further edits before the final version of record.

Subject of Research: Time to recovery and predictors among COVID-19 patients under home-based isolation and care in Addis Ababa, Ethiopia

Article Title: Survival analysis of recovery among COVID‑19 patients managed under home‑based isolation and care: a retrospective cohort study, Addis Ababa, Ethiopia

Article References: Gizaw, A. B., Baruda, S. K., Wondimagegnehu, A., Aga, A. M., Niguse, D. M., Woldemichael, D. N., & Asfaw, Z. G. (2026). Survival analysis of recovery among COVID‑19 patients managed under home‑based isolation and care: a retrospective cohort study, Addis Ababa, Ethiopia. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14662-z

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14662-z

Keywords: COVID-19, home-based isolation, Ethiopia, Addis Ababa, survival analysis, recovery time, vaccination, Cox regression, retrospective cohort, public health, Survival, analysis

News Source: Ophelia Keating. (October 29, 2026). Most COVID-19 Patients in Addis Ababa Recovered Within a Week of Home-Based Care. Scienmag.

Tags: Addis AbabaanalysisCOVID-19Cox regressionEthiopiahome-based isolationPublic Healthrecovery timeRetrospective Cohortsurvivalsurvival analysisvaccination
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.